Company intelligence / Profile preview
Irazú Oncology
Baltimore, Maryland, USAirazuoncology.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Irazú Oncology’s lead candidate, IRZ‑01, has demonstrated complete tumor remissions and durable immune responses in preclinical models. The company is currently conducting IND-enabling studies and plans to file an IND with the FDA to initiate Phase 1 clinical trials targeting multiple solid tumors.
- Therapeutic areas
- Oncology
- Modalities
- Bacterial outer membrane vesicles (OMVs) as immunotherapy delivery vehiclesEngineered bacterial nanoparticles for antigen delivery
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
University of Maryland Center for Vaccine Development and Global Health (foundational research partner)Connect Labs Baltimore at University of Maryland BioPark (facility partnership)Supported by TEDCO’s Life Sciences Investment Fund, Wexford SciTech Fund, University System of Maryland Momentum Fund, Abell Foundation
Beyond the preview
Go deeper on Irazú Oncology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Irazú Oncology.